Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 37 results.
User Information
Export Records
  1. 1.   Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy
  2. Rosa, Lorena; Cook, Paz; Pfeiffer, Ruth M; Kemp,Troy; Hildesheim, Allan; Pehlivanoglu, Burcin; Adsay, Volkan; Bellolio, Enrique; Araya, Juan Carlos; Pinto,Ligia; Ferreccio, Catterina; Aguayo, Gloria; Viñuela, Eduardo; Koshiol, Jill
  3. International Journal of Cancer. 2024, Oct 31;
  1. 2.   TPPP-BRD9 Fusion-Related Gallbladder Carcinomas are Frequently Associated with Intracholecystic Neoplasia, Neuroendocrine Carcinoma, and a Distinctive Small Tubular-Type Adenocarcinoma Commonly Accompanied with a Syringomatous Pattern
  2. Pehlivanoglu, Burcin; Araya, Juan Carlos; Lawrence,Scott; Roa, Juan Carlos; Balci, Serdar; Andersen, Jesper B; Rashid, Asif; Hsing, Ann W; Zhu, Bin; Gao, Yu-Tang; Koshiol, Jill; Adsay, Volkan
  3. Human Pathology. 2024, Jul 05; 150: 67-73.
  1. 3.   Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
  2. Koutros, Stella; Kiemeney, Lambertus A; Pal Choudhury, Parichoy; Milne, Roger L; Lopez de Maturana, Evangelina; Ye, Yuanqing; Joseph, Vijai; Florez-Vargas, Oscar; Dyrskjøt, Lars; Figueroa, Jonine; Dutta, Diptavo; Giles, Graham G; Hildebrandt, Michelle A T; Offit, Kenneth; Kogevinas, Manolis; Weiderpass, Elisabete; McCullough, Marjorie L; Freedman, Neal D; Albanes, Demetrius; Kooperberg, Charles; Cortessis, Victoria K; Karagas, Margaret R; Johnson, Alison; Schwenn, Molly R; Baris, Dalsu; Furberg, Helena; Bajorin, Dean F; Cussenot, Olivier; Cancel-Tassin, Geraldine; Benhamou, Simone; Kraft, Peter; Porru, Stefano; Carta, Angela; Bishop, Timothy; Southey, Melissa C; Matullo, Giuseppe; Fletcher, Tony; Kumar, Rajiv; Taylor, Jack A; Lamy, Philippe; Prip, Frederik; Kalisz, Mark; Weinstein, Stephanie J; Hengstler, Jan G; Selinski, Silvia; Harland, Mark; Teo, Mark; Kiltie, Anne E; Tardón, Adonina; Serra, Consol; Carrato, Alfredo; García-Closas, Reina; Lloreta, Josep; Schned, Alan; Lenz,Petra; Riboli, Elio; Brennan, Paul; Tjønneland, Anne; Otto, Thomas; Ovsiannikov, Daniel; Volkert, Frank; Vermeulen, Sita H; Aben, Katja K; Galesloot, Tessel E; Turman, Constance; De Vivo, Immaculata; Giovannucci, Edward; Hunter, David J; Hohensee, Chancellor; Hunt, Rebecca; Patel, Alpa V; Huang, Wen-Yi; Thorleifsson, Gudmar; Gago-Dominguez, Manuela; Amiano, Pilar; Golka, Klaus; Stern, Mariana C; Yan, Wusheng; Liu,Jia; Li,Shengchao; Katta,Shilpa; Hutchinson,Amy; Hicks,Belynda; Wheeler, William A; Purdue, Mark P; McGlynn, Katherine A; Kitahara, Cari M; Haiman, Christopher A; Greene, Mark H; Rafnar, Thorunn; Chatterjee, Nilanjan; Chanock, Stephen J; Wu, Xifeng; Real, Francisco X; Silverman, Debra T; Garcia-Closas, Montserrat; Stefansson, Kari; Prokunina-Olsson, Ludmila; Malats, Núria; Rothman, Nathaniel
  3. European Urology. 2023, Jul; 48(1): 127-137.
  1. 4.   NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
  2. Salomé, Bérengère; Sfakianos, John P; Ranti, Daniel; Daza, Jorge; Bieber, Christine; Charap, Andrew; Hammer, Christian; Banchereau, Romain; Farkas, Adam M; Ruan, Dan Fu; Izadmehr, Sudeh; Geanon, Daniel; Kelly, Geoffrey; de Real, Ronaldo M; Lee, Brian; Beaumont, Kristin G; Shroff, Sanjana; Wang, Yuanshuo A; Wang, Ying-Chih; Thin, Tin Htwe; Garcia-Barros, Monica; Hegewisch-Solloa, Everardo; Mace, Emily M; Wang, Li; O'Donnell, Timothy; Chowell, Diego; Fernandez-Rodriguez, Ruben; Skobe, Mihaela; Taylor, Nicole; Kim-Schulze, Seunghee; Sebra, Robert P; Palmer, Doug; Clancy-Thompson, Eleanor; Hammond, Scott; Kamphorst, Alice O; Malmberg, Karl-Johan; Marcenaro, Emanuela; Romero, Pedro; Brody, Rachel; Viard,Mathias; Yuki,Yuko; Martin,Pat; Carrington,Mary; Mehrazin, Reza; Wiklund, Peter; Mellman, Ira; Mariathasan, Sanjeev; Zhu, Jun; Galsky, Matthew D; Bhardwaj, Nina; Horowitz, Amir
  3. Cancer Cell. 2022, Sep 12; 40(9): 1027-1043.e9.
  1. 5.   Integrative molecular characterization of gallbladder cancer reveals microenvironment-associated subtypes
  2. Nepal, Chirag; Zhu, Bin; O'Rourke, Colm J; Bhatt, Deepak Kumar; Lee, Donghyuk; Song, Lei; Wang, Difei; Van Dyke, Alison; Choo-Wosoba, Hyoyoung; Liu, Zhiwei; Hildesheim, Allan; Goldstein, Alisa M; Dean, Michael; LaFuente-Barquero, Juan; Lawrence,Scott; Mutreja,Karun; Olanich,Mary; Bermejo, Justo Lorenzo; Ferreccio, Catterina; Roa, Juan Carlos; Rashid, Asif; Hsing, Ann W; Gao, Yu-Tang; Chanock, Stephen J; Araya, Juan Carlos; Andersen, Jesper B; Koshiol, Jill
  3. Journal of hepatology. 2020, May; 74(5): 1132-1144.
  1. 6.   Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes
  2. Koutros, Stella; Kogevinas, Manolis; Friesen, Melissa C; Stewart, Patricia A; Baris, Dalsu; Karagas, Margaret R; Schwenn, Molly; Johnson, Alison; Monawar Hosain, G M; Serra, Consol; Tardon, Adonina; Carrato, Alfredo; Garcia-Closas, Reina; Moore, Lee E; Nickerson, Michael L; Hewitt, Stephen M; Lenz,Petra; Schned, Alan R; Lloreta, Josep; Allory, Yves; Zhang, Haoyu; Chatterjee, Nilanjan; Garcia-Closas, Montserrat; Rothman, Nathaniel; Malats, Núria; Silverman, Debra T
  3. Environment international. 2020, Feb; 135: 105346.
  1. 7.   Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study
  2. Turkbey, Baris; Czarniecki, Marcin; Shih, Joanna H; Harmon,Stephanie; Agarwal, Piyush K; Apolo, Andrea B; Citrin, Deborah E; Gulley, James L; Harisinghani, Mukesh; Madan, Ravi A; Metwalli, Adam R; Paquette, Edmond; Pinto, Peter A; Rais-Bahrami, Soroush; Rowe, Lindsay S; Wood, Bradford J; Jacobs,Paula; Lindenberg, Liza; Dahut, William; Choyke, Peter L
  3. AJR. American journal of roentgenology. 2020, Jan; 214(1): 105-113.
  1. 8.   A spontaneously metastatic model of bladder cancer: imaging characterization
  2. Tatum, James L; Kalen,Joseph; Jacobs, Paula M; Ileva,Lilia; Riffle,Lisa; Hollingshead,Melinda; Doroshow, James H
  3. Journal of translational medicine. 2019, Dec 19; 17(1): 425.
  1. 9.   Bladder urothelial carcinoma producing insulin-like growth factor II: A case report
  2. Funada, Satoshi; Kita, Yuki; Okada, Yoshiyuki; Kobayashi, Takashi; Teramoto, Yuki; Shibuya, Shinsuke; Saito, Ryoichi; Murakami, Kaoru; Matsumoto, Keiyu; Feng,Yang; Dimitrov, Dimiter S; Inoue, Takahiro; Ogawa, Osamu
  3. IJU case reports. 2018, Nov; 1(1): 9-12.
  1. 10.   Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions
  2. Koshiol, Jill; Gao, Yu-Tang; Corbel, Amanda; Kemp, Troy; Shen, Ming-Chang; Hildesheim, Allan; Hsing, Ann W; Rashid, Asif; Wang, Bingsheng; Pfeiffer, Ruth M; Pinto, Ligia
  3. Cancer epidemiology. 2018, Jun; 54: 25-30.
  1. 11.   Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation
  2. Van Dyke, A. L.; Kemp, T. J.; Corbel, A. F.; Zhu, B.; Gao, Y. T.; Wang, B. S.; Rashid, A.; Shen, M. C.; Hildesheim, A.; Hsing, A. W.; Pinto, L. A.; Koshiol, J.
  3. Annals of Epidemiology. 2016, Oct; 26(10): 704-709.
  1. 12.   Invited Commentary: More Surprises From a Gene Desert
  2. Wacholder, S.; Yeager, M.; Liao, L. M.
  3. American Journal of Epidemiology. 2012, Mar; 175(6): 488-491.
  1. 13.   Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice
  2. Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology Letters. 2012, Mar; 209(2): 179-185.
  1. 14.   The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation
  2. von Eyss, B.; Maaskola, J.; Memczak, S.; Mollmann, K.; Schuetz, A.; Loddenkemper, C.; Tanh, M. D.; Otto, A.; Muegge, K.; Heinemann, U.; Rajewsky, N.; Ziebold, U.
  3. Embo Journal. 2012, Feb; 31(4): 972-985.
  1. 15.   Global proteomics and metabolomics in cancer biomarker discovery
  2. Issaq, H. J.; Fox, S. D.; Chan, K. C.; Veenstra, T. D.
  3. Journal of Separation Science. 2011, Dec; 34(24): 3484-3492.
  1. 16.   Normalization of Proliferation and Tight Junction Formation in Bladder Epithelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome by d-Proline and d-Pipecolic Acid Derivatives of Antiproliferative Factor
  2. Keay, S.; Kaczmarek, P.; Zhang, C. O.; Koch, K.; Szekely, Z.; Barchi, J. J.; Michejda, C.
  3. Chemical Biology & Drug Design. 2011, Jun; 77(6): 421-430.
  1. 17.   Cancer biomarker discovery: Opportunities and pitfalls in analytical methods
  2. Issaq, H. J.; Waybright, T. J.; Veenstra, T. D.
  3. Electrophoresis. 2011, Apr; 32(9): 967-975.
  1. 18.   Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives
  2. Kaczmarek, P.; Tocci, G. M.; Keay, S. K.; Adams, K. M.; Zhang, C. O.; Koch, K. R.; Grkovic, D.; Guo, L.; Michejda, C. J.; Barchi, J. J.
  3. Acs Medicinal Chemistry Letters. 2010, Nov; 1(8): 390-394.
  1. 19.   Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells
  2. Hour, T. C.; Lai, Y. L.; Kuan, C. I.; Chou, C. K.; Wang, J. M.; Tu, H. Y.; Hu, H. T.; Lin, C. S.; Wu, W. J.; Pu, Y. S.; Sterneck, E.; Huang, A. M.
  3. Biochemical Pharmacology. 2010, Aug; 80(3): 325-334.
  1. 20.   UBIAD1 Mutation Alters a Mitochondrial Prenyltransferase to Cause Schnyder Corneal Dystrophy
  2. Nickerson, M. L.; Kostiha, B. N.; Brandt, W.; Fredericks, W.; Xu, K. P.; Yu, F. S.; Gold, B.; Chodosh, J.; Goldberg, M.; Lu, D. W.; Yamada, M.; Tervo, T. M.; Grutzmacher, R.; Croasdale, C.; Hoeltzenbein, M.; Sutphin, J.; Malkowicz, S. B.; Wessjohann, L.; Kruth, H. S.; Dean, M.; Weiss, J. S.
  3. Plos One. 2010, May; 5(5): e10760.
  1. 21.   Arsenic Exposure In Utero and Nonepidermal Proliferative Response in Adulthood in Tg.AC Mice
  2. Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. International Journal of Toxicology. 2010, May; 29(3): 291-296.
  1. 22.   Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray
  2. Oyelaran, O.; Gildersleeve, J. C.
  3. Proteomics Clinical Applications. 2010, Mar; 4(3): 285-294.
  1. 23.   Short and sweet: evolution of a small glycopeptide from a bladder disorder to an anticancer lead
  2. Barchi, J. J., Jr.; Kaczmarek, P.
  3. Molecular Interventions. 2009, Feb; 9(1): 14-7.
  1. 24.   Urothelial Overexpression of Insulin-Like Growth Factor-1 Increases Susceptibility to p-Cresidine-Induced Bladder Carcinogenesis in Transgenic Mice
  2. Hursting, S. D.; Perkins, S. N.; Lavigne, J. A.; Beltran, L.; Haines, D. C.; Hill, H. L.; Alvord, W. G.; Barrett, J. C.; DiGiovanni, J.
  3. Molecular Carcinogenesis. 2009 48(8): 671-677.
  1. 25.   Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry
  2. Issaq, H. J.; Nativ, O.; Waybright, T.; Luke, B.; Veenstra, T. D.; Issaq, E. J.; Kravstov, A.; Mullerad, M.
  3. Journal of Urology. 2008 179(6): 2422-2426.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel